Xiong Xiegang, an executive at Cloopen Group Holding Ltd, has reported substantial changes to his ownership of the company following a merger. This filing, dated October 29, 2026, is significant as it reflects the implications of the recent merger on executive ownership and compensation.
Background
Cloopen Group Holding Ltd operates in the prepackaged software sector, as indicated by its Standard Industrial Classification (SIC) code. The company is known for providing innovative software solutions and has been active in the market for several years. Recent filings indicate that Xiong Xiegang has been involved with the company, holding various titles including Chief Product Officer and Chief Technology Officer.
What the Filing Says
The recent SEC filing reveals that Xiong disposed of a total of 1,210,750 Class A ordinary shares as part of the merger agreement dated May 12, 2026. This included the disposal of 363,225 shares and 847,525 shares, which were exchanged for cash. The filing states, "Each Class A ordinary share was canceled and ceased to exist in exchange for the right to receive US$0.4940 in cash per Class A Ordinary Share, without interest." Additionally, Xiong reported transactions involving options and restricted share units, indicating a comprehensive restructuring of his holdings.
Impact
This ownership change may affect various stakeholders, including the company's executives, shareholders, and employees. The filing highlights that Xiong's previous shares were held by Flawless Success Limited, acting as a nominee for an employee trust. This transition may influence employee morale and perceptions of executive compensation within the company.
What's Next
The filing does not specify what happens next regarding Xiong's future ownership or any potential new filings. However, the implications of the merger and the changes in ownership will likely continue to resonate within the industry.
Read Next
Whims James Acquires 1,782 Shares of Synaptics Inc Stock
EEME Energy SPV I, LLC Supports XCF Global, Opposes Stock Split
Chan Nelson Acquires 1,782 Shares of Synaptics Inc
Cavitation Technologies responds to BrightFlixx tender offer
RiverNorth Capital updates beneficial ownership in SEC filing
Organigram to Acquire Aurora Cannabis for C$7.80 per Share










